newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics to Present at Upcoming September Virtual Investor Conferences

BOSTON, Sept. 7, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, tod